dc.contributor.author | Niriella, M.A. | |
dc.date.accessioned | 2024-11-12T05:07:07Z | |
dc.date.available | 2024-11-12T05:07:07Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Ceylon Medical Journal. 2024; 68(3): 91-94. | en_US |
dc.identifier.issn | 2386-1274(Electronic) | |
dc.identifier.issn | 0009-0875(Print) | |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/28729 | |
dc.description | Not indexed | en_US |
dc.description.abstract | No abstract available | en_US |
dc.language.iso | en | en_US |
dc.publisher | The Sri Lanka Medical Association | en_US |
dc.subject | Nomenclature | en_US |
dc.subject | Fatty liver | en_US |
dc.subject | Fatty liver disease | en_US |
dc.subject | Steatotic liver disease | en_US |
dc.subject | Metabolic dysfunction | en_US |
dc.subject | NAFLD | en_US |
dc.subject | MAFLD | en_US |
dc.subject | MASLD | en_US |
dc.title | “What’s in a name?”–The implications of change in nomenclature for fatty liver disease from NAFLD to MAFLD to MASLD | en_US |
dc.type | Article | en_US |